Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-23T05:00:57.657Z Has data issue: false hasContentIssue false

Veterinary Medicines in Britain: Output and Industry Organisation since 19001

Published online by Cambridge University Press:  17 May 2012

Andrew Godley
Affiliation:
Andrew Godley, Professor of Management, and T.A.B Corley, Senior Lecturer, Henley Business School, University of Reading, Whiteknights, Reading RG6 6UD, UK. Email: [email protected] and [email protected]
T.A.B. Corley
Affiliation:
Andrew Godley, Professor of Management, and T.A.B Corley, Senior Lecturer, Henley Business School, University of Reading, Whiteknights, Reading RG6 6UD, UK. Email: [email protected] and [email protected]
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The historical development and economic impact of pharmaceuticals in the UK are nowadays reasonably well documented. That industry has become the most profitable and fast growing of the country's high-tech industries. Its member firms undertake more than one-fifth of the national research and development (R&D) activities, one half being carried out in Britain, and currently achieve a £2.4 billion favourable trade balance with the rest of the world.

Type
Articles
Copyright
Copyright © The Author(s) 2011. Published by Cambridge University Press

References

1 While this is a summary of the paper given at the conference ‘The Future of Medical History’ in July 2010, the full paper is published as ‘The Veterinary Medicine Industry in Britain in the Twentieth Century’, Economic History Review forthcoming (DOI: 10.1111/j.1468-0289.2010.00553.x). In the interests of brevity, we have therefore omitted listing sources used in footnote references here, and would instead direct interested readers to the full article.